PRMT6 and glioblastoma: Thus, we examined PRMT6 and H3R2me2a in the 150 bp∼−1kbp region spanning the promoter of CDC20 in GBM cells and revealed positive enrichment for PRMT6 and H3R2me2a, in the 1000 bp∼200 bp upstream of the CDC20 transcriptional start site (Primer F1-F4) (Fig. 4G, H and Fig. S3H, I).